Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 229-861-2 | CAS number: 6790-58-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 2008-07-16 to 2008-10-16
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Remarks:
- Study performed according to OECD test guideline No. 476 and in compliance with GLP with acceptable restrictions. In the absence of S9, in both experiments, the required level of toxicity was not achieved. Precipitate was observed in Exp. I and IIA but not in IIB. A statement from the study Director is attached to this ESR (see "1193806statement18082011".
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 009
- Report date:
- 2009
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- yes
- Remarks:
- In the absence of S9, in both experiments, the required level of toxicity was not achieved. Precipitate was observed in Exp. I and IIA but not in IIB. Statement from the study Director is attached to this ESR.
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.10 (Mutagenicity - In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- yes
- Remarks:
- In the absence of S9, in both experiments, the required level of toxicity was not achieved. Precipitate was observed in Exp. I and IIA but not in IIB. Statement from the study Director is attached to this ESR.
- Principles of method if other than guideline:
- not applicable
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- OECD GLP (Inspected on 2nd September 2006 / Signed on 19th January 2007)
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- [3aR-(3aα,5aβ,9aα,9bβ)]-dodecahydro-3a,6,6,9a-tetramethylnaphtho[2,1-b]furan
- EC Number:
- 229-861-2
- EC Name:
- [3aR-(3aα,5aβ,9aα,9bβ)]-dodecahydro-3a,6,6,9a-tetramethylnaphtho[2,1-b]furan
- Cas Number:
- 6790-58-5
- Molecular formula:
- C16H28O
- IUPAC Name:
- (3aR,5aS,9aS,9bR)-3a,6,6,9a-tetramethyl-dodecahydronaphtho[2,1-b]furan
- Reference substance name:
- (3aS,5aR,9aR,9bS)-3a,6,6,9a-Tetramethyldodecahydronaphtho[2,1-b]furan
- Cas Number:
- 234431-64-2
- Molecular formula:
- C16H28O
- IUPAC Name:
- (3aS,5aR,9aR,9bS)-3a,6,6,9a-Tetramethyldodecahydronaphtho[2,1-b]furan
- Test material form:
- solid
- Details on test material:
- - Physical state: solid
- Stability under test conditions: at least 7 days when kept at room temperature.
- Storage condition of test material: In the refrigerator (2 - 8 °C), protected from light
- Molecular formula : C16 H28 O
- Molecular weight : 236.4 g/mol
Constituent 1
Constituent 2
Method
- Target gene:
- Not applicable
Species / strain
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- - Type and identity of media: About 5 x 105 cells per flask were seeded into 15 mL of MEM (Minimal Essential Medium; Seromed, 12247 Berlin, Germany) supplemented with 10 % foetal calf serum (FCS; PAA Laboratories GmbH, 35091 Cölbe, Germany). Additionally, the medium was supplemented with 1 % 100x Penicillin/ Streptomycin solution (10.000 Units/mL Penicillin, 10 mg/mL Streptomycin; PAA Laboratories GmbH, 35091 Cölbe, Germany) and 1 % Amphotericin B (250 Og/mL, PAA Laboratories GmbH, 35091 Cölbe, Germany).
The cells were sub-cultured twice weekly. The cell cultures were incubated at 37 °C in a humidified atmosphere with 1.5 % carbon dioxide (98.5 % air).
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: yes
- Periodically checked for karyotype stability: yes
- Periodically "cleansed" against high spontaneous background: no data - Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9-mix from Phenobarbital/B-Naphthoflavone induced rat liver S9
- Test concentrations with justification for top dose:
- - Experiment I: without S9-mix: from 4.7 to 1200 µg/mL (approx. 5.1 mM) / with S9-mix: from 2.4 to 600 µg/mL (approx. 2.5 mM).
- Experiment IIA: without S9-mix: from 0.3 to 75 µg/mL / with S9-mix: from 18.8 to 600 µg/mL.
- Experiment IIB: with S9-mix: from 4.7 to 600 µg/mL. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: tetrahydrofuran (THF)
- Justification for choice of solvent/vehicle: The solvent was chosen for its solubility properties and its relative non-toxicity to the cell cultures.
Controlsopen allclose all
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- 500 and 900 µg/mL (4.0 and 7.2 mM)
- Positive control substance:
- ethylmethanesulphonate
- Remarks:
- Without metabolic activation
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- 1.4 µg/mL (5.0 mM)
- Positive control substance:
- cyclophosphamide
- Remarks:
- With metabolic activation
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Exposure duration: Experiment I: 4 h with and without S9-mix
Experiment IIA: 18 h without S9-mix / 4 h with S9-mix
Experiment IIB: 4 h with S9-mix
- Expression time (cells in growth medium): 14 h after wash-off (except experiment IIA without S9-mix)
- Fixation time (start of exposure up to fixation or harvest of cells): 18 h
SPINDLE INHIBITOR (cytogenetic assays): Colcemid (0.2 µg/mL culture medium)
STAIN (for cytogenetic assays): Giemsa
NUMBER OF REPLICATIONS: 2
NUMBER OF CELLS EVALUATED: at least 100 metaphases per culture, except for positive controls in Experiment I and II in the absence of S9-mix, where only 50 metaphases were scored per culture.
DETERMINATION OF CYTOTOXICITY
- Method: Cell number and mitotic index
For evaluation of cytotoxicity indicated by reduced cell numbers two additional cultures per test item and solvent control group, not treated with colcemid, were set up in parallel. These cultures were stained after 18 hours in order to determine microscopically the cell number within 10 defined fields per coded slide. The cell number of the treatment groups is given in percentage compared to the respective solvent control.
OTHER EXAMINATIONS:
- Determination of polyploidy: yes
- Determination of endoreplication: yes - Evaluation criteria:
- A test item is classified as non-clastogenic if:
- the number of induced structural chromosome aberrations in all scored dose groups is in the range of the laboratory’s historical control data range and/or
- no significant increase of the number of structural chromosome aberrations is observed.
A test item is classified as clastogenic if:
- the number of induced structural chromosome aberrations is not in the range of the laboratory’s historical control data range and
- either a concentration-related or a significant increase of the number of structural chromosome aberrations is observed.
A test item can be classified as aneugenic if:
- the number of induced numerical aberrations is not in the range of the laboratory’s historical control data range. - Statistics:
- Statistical significance was confirmed by means of the Fisher’s exact test (p < 0.05).
Results and discussion
Test results
- Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: No relevant influence (Exp. I: solvent control pH 7.4 versus pH 7.3 at 1200 µ/mL; Exp. IIA: solvent control pH 7.3 versus and pH 7.3 at 75 µg/mL).
- Effects of osmolality: No relevant influence (Exp. I: solvent control 354 mOsm versus 370 mOsm at 1200 µg/mL; Exp. IIA: solvent control 355 mOsm versus 380 mOsm at 75 µg/mL).
- Evaporation from medium: the test material is not a VOC
- Water solubility: The test substance was not sufficiently soluble in water for water to be used as the vehicle.
- Precipitation: In Experiment I precipitation of the test item in culture medium was observed after 4 hours treatment with 1200 µg/mL in the absence of S9 mix and 300 µg/mL and above in the presence of S9 mix. In Experiment IIA in the presence of S9 mix precipitation occurred after 4 hours treatment with 300 µg/mL and above.
- Other confounding effects: none
COMPARISON WITH HISTORICAL CONTROL DATA: all vehicle and solvent controls were in the range of historical laboratory control data.
ADDITIONAL INFORMATION ON CYTOTOXICITY: In Experiments I and IIA in the absence of S9 mix, concentrations showing clear cytotoxicity were not scorable for cytogenetic damage. In Experiment I in the presence of S9 mix no cytotoxicity indicated by reduced cell numbers and/ or reduced mitotic indices of below 50 % of control was observed up to the highest evaluated concentration, where test item precipitation occurred. In Experiment IIA in the presence of S9 mix, 75.0 µg/mL induced unexpected cytotoxicity. In Experiment IIB no cytotoxicity indicated by reduced cell numbers and/ or reduced mitotic indices of below 50 % of control was observed up to the highest applied concentration.
Any other information on results incl. tables
Table 7.6.1/2: Summary of results
Exp. |
Test concentration (µg/mL) |
Cell number (% of control) |
Mitotic indices (% of control) |
Endomitotic cells (%)* |
Polyploid cells (%)** |
Aberrant cells (%) |
||
Incl. gaps** |
Excl. gaps** |
With exchanges |
||||||
Exposure period 4 h without S9-mix |
||||||||
I |
Solvent control1 |
100.0 |
100.0 |
0.0 |
3.4 |
3.0 |
2.0 |
0.0 |
Positive control2# |
n.t. |
85.0 |
0.0 |
5.6 |
31.0 |
30.0S |
18.0 |
|
4.7 |
110.8 |
113.3 |
0.0 |
3.4 |
1.5 |
1.5 |
0.0 |
|
9.4 |
110.3 |
111.3 |
0.0 |
3.6 |
3.0 |
3.0 |
0.0 |
|
18.8 |
101.9 |
97.3 |
0.0 |
4.3 |
2.5 |
1.5 |
0.0 |
|
Exposure period 18 h without S9-mix |
||||||||
IIA |
Solvent control1 |
100.0 |
100.0 |
0.1 |
2.6 |
2.5 |
1.5 |
0.0 |
Positive control3# |
n.t. |
81.0 |
0.0 |
2.5 |
36.0 |
35.0S |
6.0 |
|
4.7 |
91.0 |
93.2 |
0.0 |
1.8 |
1.0 |
1.0 |
0.0 |
|
9.4 |
106.4 |
113.3 |
0.1 |
3.0 |
1.0 |
1.0 |
0.0 |
|
18.8 |
66.2 |
101.7 |
0.0 |
2.5 |
1.0 |
1.0 |
0.5 |
|
Exposure period 4 h with S9-mix |
||||||||
I |
Solvent control1 |
100.0 |
100.0 |
0.1 |
4.8 |
2.5 |
2.0 |
1.0 |
Positive control4# |
n.t. |
69.6 |
0.0 |
2.9 |
19.5 |
19.0S |
4.5 |
|
75.0 |
97.1 |
92.7 |
0.1 |
3.9 |
2.5 |
2.0 |
0.0 |
|
150.0 |
92.9 |
96.0 |
0.0 |
4.5 |
2.5 |
2.0 |
0.0 |
|
300.0 |
98.9 |
93.4 |
0.0 |
4.9 |
2.5 |
1.5 |
0.0 |
|
IIA |
Solvent control1 |
100.0 |
100.0 |
0.1 |
2.9 |
1.0 |
1.0 |
0.0 |
Positive control4# |
n.t. |
73.8 |
0.0 |
2.6 |
22.0 |
21.5S |
10.0 |
|
37.5 |
103.7 |
100.6 |
0.1 |
2.2 |
2.0 |
1.5 |
0.5 |
|
75.0 |
31.6 |
27.4 |
n.e. |
n.e. |
n.e. |
n.e. |
n.e. |
|
150.0## |
75.9 |
77.8 |
0.0 |
2.6 |
5.8 |
5.8S |
1.5 |
|
300.0##P |
118.1 |
86.8 |
0.2 |
1.9 |
4.3 |
3.8S |
0.8 |
|
IIB |
Solvent control1 |
100.0 |
100.0 |
0.1 |
2.9 |
1.0 |
1.0 |
0.0 |
Positive control4# |
n.t. |
71.3 |
0.0 |
1.8 |
14.0 |
13.5S |
4.5 |
|
37.5 |
96.1 |
76.8 |
0.5*** |
2.6 |
0.0 |
0.0 |
0.0 |
|
75.0 |
91.6 |
89.0 |
0.1 |
2.1 |
3.0 |
3.0S |
0.5 |
|
150.0 |
91.9 |
90.4 |
0.1 |
2.4 |
1.5 |
1.5 |
0.0 |
|
300.0 |
95.7 |
94.1 |
0.0 |
2.1 |
2.5 |
2.0S |
0.0 |
Red characters in bold: Aberration frequency exceeding the lab’s historical control range data.
* Evaluation of 1000 metaphases per culture
** Inclusive cells carrying exchanges
*** Evaluation of 2000 metaphases per culture
#Evaluation of 50 metaphases per culture
##Evaluation of 200 metaphases per culture
n.e. Not evaluable due to unexpected cytotoxicity
n. t. Not tested
PPrecipitation occurred
SAberration frequency statistically significant higher than corresponding control values
1THF 0.5 % (v/v)
2EMS 900.0 µg/mL
3EMS 500.0 µg/mL
4CPA 1.4 µg/mL
Applicant's summary and conclusion
- Conclusions:
- ST 10 C 08 did not induce a toxicologically significant increase in the frequency of cells with aberrations or polyploid cells in either the presence or absence of a metabolising system. ST 10 C 08 is therefore considered to be non clastogenic to human lymphocytes in vitro.
- Executive summary:
In an in vitro chromosome aberration test performed according to OECD guideline No 473 and in compliance with GLP, V79 cells of the Chinese Hamster were exposed to ST 10 C 08 diluted in tetrahydrofuran (THF) in three independent experiments. The following study design was performed:
Without S9-mix
With S9-mix
Exp. I
Exp. IIA
Exp. I, IIA, and IIB
Exposure period
4 h
18 h
4 h
Recovery
14 h
-
14 h
Preparation interval
18 h
18 h
18 h
In each experimental group two parallel cultures were set up. At least 100 metaphases per culture were scored for structural chromosome aberrations, except for the positive controls in Experiments I and II in the absence of S9 mix, where only 50 metaphases were scored.
The highest applied concentration (without S9 mix: 1200 µg/mL, approx. 5.0 mM; with S9 mix: 600 µg/mL, approx. 2.5 mM) was chosen with regard to the solubility properties of the test item in THF with respect to the current OECD Guideline 473. Dose selection for the cytogenetic experiments was performed considering the toxicity data and the occurrence of precipitation.
In Experiments I and IIA in the absence of S9 mix, concentrations showing clear cytotoxicity were not scorable for cytogenetic damage. In Experiment I in the presence of S9 mix no cytotoxicity was observed. In Experiment IIA in the presence of S9 mix only at a concentration of 75.0 µg/mL cytotoxicity was observed. In Experiment IIB no cytotoxicity was observed up to the highest applied concentration.
In Experiment I no clastogenicity was observed at the evaluated concentrations either with or without metabolic activation.
In Experiment IIA in the presence of S9 mix cells treated with 75.0 µg/mL were not evaluable for cytogenetic damage due to unexpected cytotoxicity. The next higher concentration (150.0 µg/mL) induced a statistically significant increase in the number of aberrant cells (5.8 % aberrant cells excluding gaps). This value exceeded the laboratory’s historical control data range (0.0 – 4.0 aberrant cells excluding gaps).
To verify these observations a confirmatory experiment IIB was performed. The clastogenic effect of the test item at a concentration of 150.0 µg/mL was not reproduced and the test item is therefore considered as non-clastogenic.
No relevant increase in polyploid metaphases was found after treatment with the test item as compared to the frequencies of the control cultures.
In the confirmatory experiment IIB treatment with 37.5 µg/mL led to a statistically significant increase in the number of endomitotic cells (0.5 %) compared to the solvent control. This effect was seen in only one of two experiments with the same study design. In addition, no dose-dependent increase in endomitotic cells was observed. Therefore, the single increased rate of endomitotic cells is regarded as biologically irrelevant.
Appropriate mutagens were used as positive controls. They induced statistically significant increases (p < 0.05) in cells with structural chromosome aberrations.
Under the experimental conditions reported, ST 10 C 08 did not induce structural chromosome aberrations as determined by the chromosome aberration test inV79cells (Chinese hamster cell line)in vitro.
This study is considered as acceptable and satisfies the requirement for in vitro mammalian chromosome aberration assay.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.